Galectin Therapeutics Inc.
DE ˙ DB ˙ US3632252025
1,88 € ↓ -0,05 (-2,59%)
2026-06-03
DEL PRIS
SecurityDE:PHPN / Galectin Therapeutics Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in PHPN / Galectin Therapeutics Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Galectin Therapeutics Inc. (DE:PHPN) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 99,110 shares of Galectin Therapeutics Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (PHPN) in the form of stock options. The firm currently holds call options representing 637,100 of underlying shares valued at $2,650,336 USD and put options representing 12,000 of underlying shares valued at $49,920 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:PHPN / Galectin Therapeutics Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -99,110 -100.00 0 -100.00
2025-11-12 2025-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 99,110 32,914 49.72 420 201.44 0.0007
2025-08-14 2025-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 66,196 66,196 140 0.0003
2024-08-14 2024-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -542 -100.00 0 -100.00
2024-05-10 2024-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 542 542 1 0.0000
2021-08-10 2021-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -2,976 -100.00 0 -100.00
2021-05-12 2021-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 2,976 -5,000 -62.69 6 -66.67 0.0000
2021-02-10 2020-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 7,976 7,976 18 0.0000
2020-11-12 2020-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -4,824 -100.00 0 -100.00
2020-08-13 2020-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 4,824 65 1.37 15 66.67 0.0001
2020-05-13 2020-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 4,759 4,759 9 0.0001
2020-02-10 2019-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -794 -100.00 0 -100.00
2019-11-12 2019-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 794 -14,768 -94.90 3 -95.38 0.0000
2019-08-09 2019-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 15,562 15,562 65 0.0006
2019-05-14 2019-03-31 13F/A-1 GALECTIN THERAPEUTICS COM NEW 363225202 0 -4,965 -100.00 0 -100.00
2019-02-05 2018-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 4,965 -42,000 -89.43 17 -93.97 0.0001
2018-11-08 2018-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 46,965 -61,526 -56.71 282 -59.13 0.0022
2018-08-13 2018-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 108,491 103,339 2,005.80 690 2,775.00 0.0059
2018-05-16 2018-03-31 13F/A-1 GALECTIN THERAPEUTICS COM NEW 363225202 5,152 5,152 24 0.0002
2018-05-10 2018-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 5,152 5,152 24
2018-02-09 2017-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -23,052 -100.00 0 -100.00
2017-11-15 2017-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 23,052 23,052 49 0.0004
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 637,100 346.46 2,650 338.74 n/a n/a n/a
2025-11-12 2025-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 142,700 684.07 604 1,489.47 n/a n/a n/a
2025-08-14 2025-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 18,200 119.28 38 280.00 n/a n/a n/a
2025-05-14 2025-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 8,300 -98.78 10 -98.86 n/a n/a n/a
2025-05-14 2024-12-31 13F/A GALECTIN THERAPEUTICS COM NEW Call 681,700 309.68 879 92.34 n/a n/a n/a
2025-02-14 2024-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 681,700 879 n/a n/a n/a
2024-11-14 2024-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 166,400 4,060.00 458 4,977.78 n/a n/a n/a
2024-08-14 2024-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 4,000 1,900.00 9 n/a n/a n/a
2024-05-10 2024-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 200 -97.62 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 8,400 -9.68 14 -23.53 n/a n/a n/a
2023-11-09 2023-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 9,300 17.72 18 54.55 n/a n/a n/a
2023-08-09 2023-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 7,900 -3.66 11 -35.29 n/a n/a n/a
2023-05-12 2023-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 8,200 331.58 17 750.00 n/a n/a n/a
2023-02-09 2022-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 1,900 -77.91 2 -85.71 n/a n/a n/a
2022-11-09 2022-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 8,600 -27.12 14 -6.67 n/a n/a n/a
2022-08-11 2022-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 11,800 -69.11 15 -75.81 n/a n/a n/a
2022-05-12 2022-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 38,200 -47.74 62 -58.94 n/a n/a n/a
2022-02-11 2021-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 73,100 -72.86 151 -85.55 n/a n/a n/a
2021-11-12 2021-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 269,300 -20.40 1,045 -3.51 n/a n/a n/a
2021-08-10 2021-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 338,300 1,078.75 1,083 1,646.77 n/a n/a n/a
2021-05-12 2021-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 28,700 160.91 62 148.00 n/a n/a n/a
2021-02-10 2020-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 11,000 -71.72 25 -75.96 n/a n/a n/a
2020-11-12 2020-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 38,900 -12.58 104 -23.53 n/a n/a n/a
2020-08-13 2020-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 44,500 57.24 136 147.27 n/a n/a n/a
2020-05-13 2020-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 28,300 -24.53 55 -48.60 n/a n/a n/a
2020-02-10 2019-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 37,500 10.95 107 -13.71 n/a n/a n/a
2019-11-12 2019-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 33,800 90.96 124 69.86 n/a n/a n/a
2019-08-09 2019-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 17,700 -81.50 73 -85.07 n/a n/a n/a
2019-05-14 2019-03-31 13F/A GALECTIN THERAPEUTICS COM NEW Call 95,700 70.89 489 154.69 n/a n/a n/a
2019-05-13 2019-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 95,700 489 n/a n/a n/a
2019-02-05 2018-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 56,000 -28.39 192 -59.15 n/a n/a n/a
2018-11-08 2018-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 78,200 134.83 470 121.70 n/a n/a n/a
2018-08-13 2018-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 33,300 -70.97 212 -61.03 n/a n/a n/a
2018-05-16 2018-03-31 13F/A GALECTIN THERAPEUTICS COM NEW Call 114,700 -62.32 544 -46.51 n/a n/a n/a
2018-05-10 2018-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 114,700 544 n/a n/a n/a
2018-02-09 2017-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 304,400 114.06 1,017 237.87 n/a n/a n/a
2017-11-15 2017-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 142,200 -22.89 301 -33.70 n/a n/a n/a
2017-08-14 2017-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 184,400 -25.37 454 -20.07 n/a n/a n/a
2017-05-10 2017-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 247,100 568 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F GALECTIN THERAPEUTICS COM NEW Put 12,000 -69.39 50 -70.48 n/a n/a n/a
2025-11-12 2025-09-30 13F GALECTIN THERAPEUTICS COM NEW Put 39,200 -52.54 166 -4.60 n/a n/a n/a
2025-08-14 2025-06-30 13F GALECTIN THERAPEUTICS COM NEW Put 82,600 103.45 174 255.10 n/a n/a n/a
2025-05-14 2025-03-31 13F GALECTIN THERAPEUTICS COM NEW Put 40,600 -11.16 50 -15.52 n/a n/a n/a
2025-05-14 2024-12-31 13F/A GALECTIN THERAPEUTICS COM NEW Put 45,700 2,076.19 59 1,060.00 n/a n/a n/a
2025-02-14 2024-12-31 13F GALECTIN THERAPEUTICS COM NEW Put 45,700 59 n/a n/a n/a
2024-11-14 2024-09-30 13F GALECTIN THERAPEUTICS COM NEW Put 2,100 6 n/a n/a n/a
2024-05-10 2024-03-31 13F GALECTIN THERAPEUTICS COM NEW Put 0 -100.00 0 n/a n/a n/a
2024-02-14 2023-12-31 13F GALECTIN THERAPEUTICS COM NEW Put 400 0.00 1 n/a n/a n/a
2023-11-09 2023-09-30 13F GALECTIN THERAPEUTICS COM NEW Put 400 0.00 1 n/a n/a n/a
2023-08-09 2023-06-30 13F GALECTIN THERAPEUTICS COM NEW Put 400 0.00 1 n/a n/a n/a
2023-05-12 2023-03-31 13F GALECTIN THERAPEUTICS COM NEW Put 400 -86.67 1 -100.00 n/a n/a n/a
2023-02-09 2022-12-31 13F GALECTIN THERAPEUTICS COM NEW Put 3,000 -70.30 3 -81.25 n/a n/a n/a
2022-11-09 2022-09-30 13F GALECTIN THERAPEUTICS COM NEW Put 10,100 -17.21 16 0.00 n/a n/a n/a
2022-08-11 2022-06-30 13F GALECTIN THERAPEUTICS COM NEW Put 12,200 -55.31 16 -63.64 n/a n/a n/a
2022-05-12 2022-03-31 13F GALECTIN THERAPEUTICS COM NEW Put 27,300 52.51 44 18.92 n/a n/a n/a
2022-02-11 2021-12-31 13F GALECTIN THERAPEUTICS COM NEW Put 17,900 -48.86 37 -72.79 n/a n/a n/a
2021-11-12 2021-09-30 13F GALECTIN THERAPEUTICS COM NEW Put 35,000 104.68 136 147.27 n/a n/a n/a
2021-08-10 2021-06-30 13F GALECTIN THERAPEUTICS COM NEW Put 17,100 557.69 55 816.67 n/a n/a n/a
2021-05-12 2021-03-31 13F GALECTIN THERAPEUTICS COM NEW Put 2,600 -55.17 6 -53.85 n/a n/a n/a
2021-02-10 2020-12-31 13F GALECTIN THERAPEUTICS COM NEW Put 5,800 -30.12 13 -40.91 n/a n/a n/a
2020-11-12 2020-09-30 13F GALECTIN THERAPEUTICS COM NEW Put 8,300 -50.89 22 -57.69 n/a n/a n/a
2020-08-13 2020-06-30 13F GALECTIN THERAPEUTICS COM NEW Put 16,900 6.29 52 67.74 n/a n/a n/a
2020-05-13 2020-03-31 13F GALECTIN THERAPEUTICS COM NEW Put 15,900 -50.00 31 -65.93 n/a n/a n/a
2020-02-10 2019-12-31 13F GALECTIN THERAPEUTICS COM NEW Put 31,800 -8.09 91 -28.35 n/a n/a n/a
2019-11-12 2019-09-30 13F GALECTIN THERAPEUTICS COM NEW Put 34,600 1.17 127 -10.56 n/a n/a n/a
2019-08-09 2019-06-30 13F GALECTIN THERAPEUTICS COM NEW Put 34,200 -60.73 142 -68.09 n/a n/a n/a
2019-05-14 2019-03-31 13F/A GALECTIN THERAPEUTICS COM NEW Put 87,100 50.69 445 124.75 n/a n/a n/a
2019-05-13 2019-03-31 13F GALECTIN THERAPEUTICS COM NEW Put 87,100 445 n/a n/a n/a
2019-02-05 2018-12-31 13F GALECTIN THERAPEUTICS COM NEW Put 57,800 -65.16 198 -80.14 n/a n/a n/a
2018-11-08 2018-09-30 13F GALECTIN THERAPEUTICS COM NEW Put 165,900 8.29 997 2.36 n/a n/a n/a
2018-08-13 2018-06-30 13F GALECTIN THERAPEUTICS COM NEW Put 153,200 167.36 974 258.09 n/a n/a n/a
2018-05-16 2018-03-31 13F/A GALECTIN THERAPEUTICS COM NEW Put 57,300 -69.01 272 -55.99 n/a n/a n/a
2018-05-10 2018-03-31 13F GALECTIN THERAPEUTICS COM NEW Put 57,300 272 n/a n/a n/a
2018-02-09 2017-12-31 13F GALECTIN THERAPEUTICS COM NEW Put 184,900 34.28 618 111.64 n/a n/a n/a
2017-11-15 2017-09-30 13F GALECTIN THERAPEUTICS COM NEW Put 137,700 31.27 292 13.18 n/a n/a n/a
2017-08-14 2017-06-30 13F GALECTIN THERAPEUTICS COM NEW Put 104,900 688.72 258 732.26 n/a n/a n/a
2017-05-10 2017-03-31 13F GALECTIN THERAPEUTICS COM NEW Put 13,300 31 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.